- Report
- March 2024
- 84 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- September 2023
- 94 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- July 2023
- 87 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- May 2022
- 87 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Book
- November 2019
- 440 Pages
- Book
- January 2022
- 400 Pages
The Cell Line Development market is a subset of the biotechnology industry that focuses on the development of cell lines for use in research and drug discovery. Cell lines are immortalized cell cultures that can be used to study the effects of drugs, toxins, and other compounds on cells. Cell lines are also used to produce biopharmaceuticals, such as monoclonal antibodies, vaccines, and gene therapies. Cell line development involves the selection, characterization, and optimization of cell lines for specific applications. This process includes the selection of the appropriate cell type, the optimization of culture conditions, and the characterization of the cell line for its suitability for the intended application.
Companies in the Cell Line Development market include Thermo Fisher Scientific, Merck KGaA, Lonza, Sartorius AG, Corning Incorporated, and Charles River Laboratories. Show Less Read more